Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAFITT SA
Original Assignee
LAFITT SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LAFITT SAfiledCriticalLAFITT SA
Priority to ES9700731UpriorityCriticalpatent/ES1036832Y/es
Publication of ES1036832UpublicationCriticalpatent/ES1036832U/es
Application grantedgrantedCritical
Publication of ES1036832YpublicationCriticalpatent/ES1036832Y/es
1.UCLAVO INTRAMEDULAR PARA FRACTURAS DEL FEMUR PROXIMAL, DEL TIPO GENERICAMENTE CONOCIDO COMO "CLAVO GAMMA", CARACTERIZADO ESENCIALMENTE PORQUE SU ESTRUCTURA COMPRENDE, EN POSICION SUPERIOR PROXIMA AL TORNILLO DE COMPRESION DESLIZANTE (1) Y PARALELAMENTE A EL, ATRAVESANDO OBLICUAMENTE HACIA ARRIBA EL CLAVO INTRAMEDULAR (2), OTRO TORNILLO (3) PROXIMAL QUE, INTRODUCIDO EN EL CUELLO FEMORAL, IMPIDE LA POSIBLE ROTACION DE LA CABEZA ALREDEDOR DEL CITADO TORNILLO DE COMPRESION (1) Y EVITA LA EVENTUALIDAD DE QUE SE PRODUZCA EL DESPRENDIMIENTO DE LA CARGA FEMORAL (EFECTO "CUT-OFF'').
ES9700731U1997-03-201997-03-20Clavo intramedular para fracturas de femur proximal.
Expired - Fee RelatedES1036832Y
(es)
Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer
8 alpha-3-hydroxyestra-1,3,5(11) tetraen-17-one (delta9(11)-dehydro-8 isoestrone its preparation andpharmaceutical composition containing it and its use